Expert Analysis - Opinion

Gilead Ruling Signals That Innovating Can Lead To Liability

By Gary Myers · February 6, 2024, 5:15 PM EST

The Court of Appeal of the State of California ruled last month that a drug manufacturer can be liable for negligence for its delay in introducing an improved version of its...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

A Tenn. Court Gets Specific On Abortion Ban Exceptions No Photo Available

Theresa Schliep

A recent decision by a Tennessee state court is one of the first since the U.S. Supreme Court's Dobbs decision to list out specific me... (more story)

Talkiatry CEO On How Digital Healthcare Has 'Matured' No Photo Available

Yeji Jesse Lee

Digital health has come a long way in recent years, but it's still got plenty of growing up to do. That's according to Robert Krayn, c... (more story)

Drug-Shortage List Under Scrutiny After FDA Reversal No Photo Available

Dan McKay

A federal agency's unusual flip-flop this month on whether to allow copycat versions of a lucrative weight-loss and diabetes drug may ... (more story)